{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
NCT04686175: Phase 1/Phase 2 Interventional Recruiting Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
(2021)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01751048: Phase 1 Interventional Completed Leishmaniasis
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04594642: Phase 1 Interventional Recruiting B-cell Non Hodgkin Lymphoma
(2021)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02639182: Phase 2 Interventional Completed Metastatic Renal Cell Carcinoma
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04648202: Phase 1 Interventional Recruiting Advanced Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04074759: Phase 1 Interventional Completed Advanced Solid Tumors
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04442126: Phase 1/Phase 2 Interventional Active, not recruiting Advanced Solid Tumor
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03696771: Phase 1 Interventional Completed NON-breast HER2+ Malignancies
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02310464: Phase 1 Interventional Completed Metastatic Gastric Cancer
(2015)
Source URL:
Class:
CONCEPT